Choline Effects - Pre-symptomatic AD

Clinical trial NCT05880849 · COMPLETED

Trial details

NCT number: NCT05880849
Sponsor: Paul E Schulz
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2023-06-26
Primary completion: 2025-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.